Company

QBiotics Group Limited

QBiotics develops small-molecule treatments for cancer and wound healing.

About

QBiotics develops tigilanol tiglate for cancers including soft tissue sarcomas and head and neck cancers, and EBC-1013 for wound healing. Founded in 2004 and based in Australia, the company raised USD 50 mn from TDM Growth Partners in March 2021. Victoria Gordon is CEO.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in